Schedule 13G ownership disclosure
CIDARA THERAPEUTICS INC
Common Stock, $0.0001 par value per share · CUSIP: 171757206
Event date: 2025-09-30
- Filing-level shares
- 3,020,990
- Percent of class
- 9.99%
- BCLS Fund III Investments, LP
Shares: 3,020,990 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-283107
- Form type
- SCHEDULE 13G/A
- Filer
- BCLS Fund III Investments, LP
- CIK
- CIK 1952107
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership